Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NovaFRA:NMR -3.92%97 EBIT per Share is €6.71 as of Mar. 2026. GuruFocus rates FRA:NMR with a GF Score™ of 97/100 and a GF Value™ of €275.10 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 760 Semiconductors companies, Nova ranks better than 72.24% on this metric.
Nova's EBIT per Share for the
three
months ended in Mar. 2026 was €1.78.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €6.71.
During the past 12 months, the average EBIT per Share Growth Rate of Nova was 17.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 18.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 26.20% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 31.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Nova's EBIT per Share or its related term are showing as below:
FRA:NMR'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -295.4 Med: 18 Max: 187
Current: 18
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Nova was 187.00% per year. The lowest was -295.40% per year. And the median was 18.00% per year.
FRA:NMR's 3-Year EBIT Growth Rate is ranked better than 72.24% of 760
companies
in the Semiconductors industry
Industry Median: -0.8
vs FRA:NMR: 18.00
Nova's EBIT for the
three
months ended in Mar. 2026 was €61.3 Mil.
Nova (FRA:NMR) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Nova EBIT per Share Related Terms
Nova EBIT per Share Historical Data
* Premium members only.
The historical data trend for Nova's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.71
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova (FRA:NMR) has a EBIT per Share of €6.71 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nova and its competitors. According to the industry distribution chart, Nova ranks #211 out of 760 companies in the Semiconductors industry, placing it in the top 27.8%.
Is Nova's EBIT per Share too high?
Nova's current EBIT per Share is €6.71. Based on the distribution chart, Nova ranks #211 out of 760 companies in the Semiconductors industry, which is above the industry midpoint. Overall, Nova has a GF Score™ of 97/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova's EBIT per Share compare to ONTO and AMKR?
According to the Semiconductors industry distribution chart, Nova ranks #211 out of 760 companies for EBIT per Share. This puts Nova in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Semiconductors company?
A good EBIT per Share depends on the Semiconductors industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nova and its competitors. Nova's current EBIT per Share is €6.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova stock overvalued right now?
Based on GuruFocus' analysis, Nova (FRA:NMR) is currently considered Significantly Overvalued. The stock's GF Value™ is €275.10, compared to a current price of €387.10 — trading 40.7% above its estimated fair value. The current EBIT per Share is €6.71. Nova's overall GF Score™ is 97/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Nova (FRA:NMR), the current EBIT per Share is €6.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova (FRA:NMR) Overvalued in 2026?
Based on GuruFocus' analysis, Nova stock appears to be overvalued.
The current stock price of €387.10 is trading 40.7% above its estimated GF Value™ of €275.10.
GuruFocus considers Nova to be Significantly Overvalued.
Key valuation signals for FRA:NMR:
EBIT per Share: €6.71
GF Value™: €275.10 vs. price of €387.10 (40.7% above fair value)
No single metric tells the full story. See the FRA:NMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.
97GF Score
Get the complete analysis for FRA:NMR
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NMR has been successfully added to your 
